Stay updated on RO5126766 in Advanced KRAS Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the RO5126766 in Advanced KRAS Lung Cancer Clinical Trial page.

Latest updates to the RO5126766 in Advanced KRAS Lung Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe record for a Phase 1 study of RO5126766 in advanced KRAS-mutant lung cancer is displayed, including its completed status, eligibility criteria, treatment plan, study locations, and outcome measures.SummaryDifference41%

- Check15 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check22 days agoChange DetectedThe 403 error screen is replaced by the ClinicalTrials.gov page shell, which displays an NIH transition notice. Study-specific details are not visible in the updated view.SummaryDifference2%

- Check29 days agoChange DetectedThe footer revision number changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now shows a 403 Forbidden message, replacing the previous study content with a generic error screen. The detailed study information, locations, and related links have been removed, leaving an access-denied page instead of the study record.SummaryDifference17%

Stay in the know with updates to RO5126766 in Advanced KRAS Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RO5126766 in Advanced KRAS Lung Cancer Clinical Trial page.